Robert Califf | |
---|---|
22nd & 25th Commissioner of Food and Drugs | |
Assumed office February 17, 2022 | |
President | Joe Biden |
Deputy | Janet Woodcock NamandjéBumpus |
Preceded by | Janet Woodcock (Acting) |
In office February 22,2016 –January 20,2017 | |
President | Barack Obama |
Preceded by | Margaret Hamburg |
Succeeded by | Scott Gottlieb |
Personal details | |
Born | 1951 (age 72–73) Anderson,South Carolina,U.S. |
Political party | Democratic |
Education | Duke University (BS,MD) |
Robert McKinnon Califf (born 1951) is an American cardiologist who currently serves as the 25th commissioner of the Food and Drug Administration.
He was first nominated to be commissioner in September 2015 by President Barack Obama [1] and he was confirmed by the U.S. Senate in February 2016, [2] serving until January 20,2017.
President Joe Biden renominated Califf to head the Food and Drug Administration on November 12,2021. [3] He was confirmed by the Senate on February 15,2022.
Prior to becoming commissioner he had served as the Deputy Commissioner of the United States Food and Drug Administration's Office of Medical Products and Tobacco since January 2015. [4] [5] [6] In 2019,he became head of medical strategy at Google's parent company,Alphabet Inc. [7]
Califf was born in Anderson,South Carolina. [8] He attended high school in Columbia,South Carolina,where he was a member of the 1969 AAAA South Carolina Championship basketball team. [9] [ unreliable source? ] He attended Duke University,graduating in 1973 summa cum laude [4] and is a member of Phi Beta Kappa. [9]
In 1978,he graduated from the Duke University School of Medicine in Durham,North Carolina, [4] and was inducted into the Alpha Omega Alpha medical honor society. [9] He left North Carolina for an internal medicine residency at the University of California,San Francisco and returned in 1980 to Duke to complete a fellowship in cardiology. [4] He is board-certified in internal medicine (1984) and cardiology (1986),and a Master of the American College of Cardiology (2006). [9]
Califf was granted tenure as professor of cardiology at Duke University School of Medicine. He was the founding director of the Duke Clinical Research Institute,which is a large academic research organization with 1000 employees [4] and an annual budget of $320 million,50-60% of which is funded from the pharmaceutical industry. [10]
Califf led strategy and policy for Alphabet’s health subsidiaries. He was the full-time head of strategy and policy for its Verily Life Sciences and Google Health divisions. [11]
Califf has led many clinical cardiology research studies,health outcomes research,health care quality,and translational research,which seeks to ensure that advances in science translate into medical care. He was a lead investigator in clinical trials testing the efficacy of the cholesterol-lowering drug combination ezetimibe/simvastatin. [12]
As of 2015,he was vice-chancellor of clinical and translational research and the Duke Translational Medicine Institute (DTMI) director. Califf is recognized by the Institute for Scientific Information as one of the top 10 most cited medical authors,with more than 1,200 peer-reviewed publications. [5]
Califf worked very closely with pharmaceutical companies at the Duke clinical trials center "convincing them to do large,expensive,and,for Duke,profitable clinical trials." [13] He was a paid consultant for Merck Sharp &Dohme,Johnson &Johnson,GlaxoSmithKline,AstraZeneca,and Eli Lilly per ProPublica from 2009 to 2013. The largest consulting payment was $87,500 by Johnson &Johnson in 2012,and "most of funds for travel or consulting under $5,000",which has been called "minimal for a physician of his stature". [14] From 2013 to 2014 he was paid a total of $52,796;the greatest amount being $6,450 from Merck Sharp &Dohme,followed by Amgen,F. Hoffmann-La Roche AG,Janssen Pharmaceutica,Daiichi Sankyo,Sanofi-Aventis,Bristol-Myers Squibb and AstraZeneca. [15] He was a director of Portola Pharmaceuticals,Inc. from July 2012 to January 26,2015, [14] an advisor for Proventys,Inc.,chairman of the medical advisory board of Regado Biosciences,Inc. and has been a member of that board since June 2,2009,and a member of the clinical advisory board of Corgentech Inc. [16] Forbes wrote that his close ties to the drug industry were why he was not nominated for the FDA Commissioner position in 2009. [13] Califf's ties to the pharmaceutical industry were criticized by the magazine The American Prospect, [17] and Democratic Senators Bernie Sanders and Joe Manchin,who announced their intention to vote against his 2021 renomination. [18]
In January 2015,Califf was appointed Deputy Commissioner of the United States Food and Drug Administration's Office of Medical Products and Tobacco,"second in scope only to being commissioner". [4] [6] In February 2015,Califf was cited as a possible successor to Margaret Hamburg,the outgoing Commissioner of the Food and Drug Administration. [19] and in September 2015,President Barack Obama nominated him to be the next FDA commissioner. [1] In February 2016,the US Senate confirmed Califf as commissioner of the Food and Drug Administration by a vote of 89-4. [20] [2] Califf stepped down from the post of FDA commissioner on January 20,2017.[ citation needed ]
On November 12,2021,President Biden announced he was nominating Califf to return as head of the FDA. [21] [22] During his hearing before the Senate HELP committee on December 14,2021,he was questioned relating to the pandemic,opioid crisis,and issues relating to abortion. Some Democrats opposed his nomination due to his corporate ties and the opioid crisis. Several Republican senators opposed his nomination because of issues relating to abortion. [23]
On January 13,2022,he was advanced out of committee by a 13-8 vote. On February 15,2022,the Senate confirmed his nomination by a 50-46 vote. [24] [25] Califf assumed office on February 17,2022.
He is a member of the Institute of Medicine (IOM). He was on the committees that recommended,for example,Medicare coverage of clinical trials and to remove ephedra from the market,and the committee on identifying and preventing medication errors. As of 2015,he is a member of the IOM Policy Committee and liaison to the Forum in Drug Discovery,Development,and Translation.
He served on the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology. [5]
The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety,tobacco products,caffeine products,dietary supplements,prescription and over-the-counter pharmaceutical drugs (medications),vaccines,biopharmaceuticals,blood transfusions,medical devices,electromagnetic radiation emitting devices (ERED),cosmetics,animal foods &feed and veterinary products.
Frank Edward Young was an American physician who served as Commissioner of Food and Drugs from 1984 to 1989 and later as a deputy assistant secretary in the United States Department of Health and Human Services. In 2013 he joined Braeburn Pharmaceuticals as executive vice president,clinical and regulatory affairs. In 2018,he became the executive vice president of clinical and regulatory affairs at TissueTech Inc.
David Aaron Kessler is an American pediatrician,attorney,author,and administrator serving as Chief Science Officer of the White House COVID-19 Response Team since 2021. Kessler was the commissioner of the Food and Drug Administration (FDA) from November 8,1990,to February 28,1997. He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed,the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments,from January to February 2021.
Rivaroxaban,sold under the brand name Xarelto among others,is an anticoagulant medication used to treat and prevent blood clots. Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. It is taken by mouth.
The Duke University School of Medicine,commonly known as Duke Med,is the medical school of Duke University. It was established in 1925 by James B. Duke.
Esperanza Alcantara Icasas-Cabral is a Filipina cardiologist and clinical pharmacologist. She served as Secretary of the Department of Health in the Philippines,taking office in January 2010 to replace Dr. Francisco Duque III after his appointment as chairperson of the Civil Service Commission. Before her appointment as Secretary of Health she was previously the Secretary of the Department of Social Welfare and Development,replacing Corazon Soliman. Dr. Cabral is married to Bienvenido Villegas Cabral,an ophthalmologist.
The Florida Department of Health is responsible for protecting the public health and safety of the residents and visitors of the state of Florida. It is a cabinet-level agency of the state government,headed by a state surgeon general who reports to the governor. The department has its headquarters in Tallahassee.
Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner,he was an oncologist serving as chief medical executive of the MD Anderson Cancer Center. In 2021,he became chief medical officer at Flagship Pioneering,the venture capital firm that launched Moderna.
The United States commissioner of food and drugs is the head of the Food and Drug Administration (FDA),an agency of the United States Department of Health and Human Services. The commissioner is appointed by the president of the United States and must be confirmed by the Senate. The commissioner reports to the secretary of health and human services.
Margaret Ann "Peggy" Hamburg is an American physician and public health administrator,who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.
Lester Mills Crawford,Jr. was an American veterinarian and former Commissioner of the U.S. Food and Drug Administration who was appointed by President George W. Bush. He served from July 18,2005 until resigning two months later in September 2005.
Steven E. Nissen is an American cardiologist,researcher and patient advocate. He was chairman of cardiovascular medicine at the Cleveland Clinic,in Cleveland,Ohio.
Brett P. Giroir is an American pediatrician. He was formerly the U.S. assistant secretary for health,a four-star admiral in the U.S. Public Health Service Commissioned Corps and an acting Food and Drug Administration commissioner.
Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council,acting chief scientist of the U.S. Food and Drug Administration (FDA),assistant commissioner for counterterrorism policy of the FDA,and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials,the development of medical countermeasures for health emergencies,and the public health responses to Ebola and Zika outbreaks.
Vivek Hallegere Murthy is a British-American physician and a vice admiral in the United States Public Health Service Commissioned Corps who has served as the 19th and 21st surgeon general of the United States under Presidents Barack Obama,Donald Trump,and Joe Biden. Murthy is the first surgeon general of Indian descent,and,during his first term as surgeon general,he was the youngest active duty flag officer in federal uniformed service.
Stephen Ostroff is an American physician. He served as acting commissioner of the U.S. Food and Drug Administration from April 1,2015,to February 21,2016.
Scott Gottlieb is an American physician,investor,and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI),a partner at the venture capital firm New Enterprise Associates (NEA),a member of the board of directors of drug maker Pfizer,Inc and gene sequencing company Illumina,Inc. and a contributor to cable financial news network CNBC and the CBS News program Face the Nation. An elected member of the National Academy of Medicine,Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book,The Miracle Century:Making Sense of the Cell Therapy Revolution,traces the scientific achievements that propelled progress in cell therapies.
The 21st Century Cures Act is a United States law enacted by the 114th United States Congress in December 2016 and then signed into law on December 13,2016. It authorized $6.3 billion in funding,mostly for the National Institutes of Health. The act was supported especially by large pharmaceutical manufacturers and was opposed especially by some consumer organizations.
Janet Woodcock is an American physician who served as Principal Deputy Commissioner of Food and Drugs from February 2022 until February 2024,having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). She joined the FDA in 1986,and has held a number of senior leadership positions there,including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.
Califf was widely seen as too linked to industry.
Payments: At a Glance 42 payments $52,796 payment total, Rank: 23 out of 564 doctors in this specialty and state 10 companies paid this doctor.